These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36848366)

  • 1. Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function.
    Seethapathy R; Wang Q; Zhao S; Strohbehn IA; Long JD; Dinulos JE; Harden D; Kadiyala VB; Moreno D; Sise ME
    PLoS One; 2023; 18(2):e0279765. PubMed ID: 36848366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Propensity Score-Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease.
    Seethapathy R; Zhao S; Long JD; Strohbehn IA; Sise ME
    Kidney360; 2022 Feb; 3(2):269-278. PubMed ID: 35373125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment.
    Chang MC; Wu PF; Ho YC; Lin WY; Wu CY; Liu SY; Liu CJ; Lin YT
    J Infect Public Health; 2024 Jul; 17(7):102460. PubMed ID: 38820894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of renal function with mortality among hospitalized patients treated with remdesivir for COVID-19.
    Gonzalez Suarez ML; Mara KC; Rivera CG; Chesdachai S; Draper E; Razonable RR
    PLoS One; 2024; 19(6):e0303896. PubMed ID: 38875257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical center.
    Chang HY; Hsu CC; Hu LF; Chou CY; Chang YL; Lu CC; Chang LJ
    Ann Med; 2024 Dec; 56(1):2361843. PubMed ID: 38830017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Valid Warning or Clinical Lore: an Evaluation of Safety Outcomes of Remdesivir in Patients with Impaired Renal Function from a Multicenter Matched Cohort.
    Ackley TW; McManus D; Topal JE; Cicali B; Shah S
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33229428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Safety of Remdesivir in Covid - 19 Patients with Estimated Glomerular Filtration Rate (eGFR) < 30 ml/min per 1.73 m^2.
    Wang S; Huynh C; Islam S; Malone B; Masani N; Joseph D
    J Intensive Care Med; 2022 Jun; 37(6):764-768. PubMed ID: 34967255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
    Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
    J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety Evaluation of Remdesivir for COVID-19 Patients with eGFR < 30 mL/min without Renal Replacement Therapy in a Japanese Single-Center Study.
    Umemura T; Mutoh Y; Mizuno T; Hagihara M; Kato H; Yamada T; Ikeda Y; Mikamo H; Ichihara T
    Healthcare (Basel); 2022 Nov; 10(11):. PubMed ID: 36421623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical safety of remdesivir therapy in COVID-19 patients with renal insufficiency.
    Park S; Kim AR; Lee J; Kang SW; Sung H; Kim MN; Chang E; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Song EH; Chong YP
    J Infect Chemother; 2024 Apr; 30(4):366-370. PubMed ID: 37935348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score.
    Sellers J; Chang J; Jones J; Hintze TD
    Pulm Pharmacol Ther; 2023 Feb; 78():102188. PubMed ID: 36603741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated glomerular filtration rate predicts 30-day mortality in medical emergency departments: Results of a prospective multi-national observational study.
    Haas L; Eckart A; Haubitz S; Mueller B; Schuetz P; Segerer S
    PLoS One; 2020; 15(4):e0230998. PubMed ID: 32251482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is remdesivir safe in patients with renal impairment? Experience at a large tertiary urban medical center.
    Sunny S; Samaroo-Campbell J; Abdallah M; Luka A; Quale J
    Infection; 2023 Feb; 51(1):247-252. PubMed ID: 35616879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Drug Events Associated With Remdesivir in Real-World Hospitalized Patients With COVID-19, Including Vulnerable Populations: A Retrospective Multicenter Study.
    Kang H; Kang CK; Im JH; Cho Y; Kang DY; Lee JY
    J Korean Med Sci; 2023 Nov; 38(44):e346. PubMed ID: 37967875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propensity score matched analysis for the safety and effectiveness of remdesivir in COVID-19 patients with renal impairment.
    Yang E; Choi HZ; Kim S; Oh DH; Ahn MY; Ham S; Lee E; Jeon J; Kim MK; Jang HC; Park SW; Choi JP
    BMC Infect Dis; 2024 Jan; 24(1):3. PubMed ID: 38166787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
    Ader F; Bouscambert-Duchamp M; Hites M; Peiffer-Smadja N; Poissy J; Belhadi D; Diallo A; Lê MP; Peytavin G; Staub T; Greil R; Guedj J; Paiva JA; Costagliola D; Yazdanpanah Y; Burdet C; Mentré F;
    Lancet Infect Dis; 2022 Feb; 22(2):209-221. PubMed ID: 34534511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remdesivir versus Favipiravir in Hospitalized Patients with Moderate to Severe COVID-19 Pneumonia: A Propensity Score-Matched Retrospective Cohort Study.
    Chavalertsakul K; Sutherasan Y; Petnak T; Thammavaranucupt K; Kirdlarp S; Boonsarngsuk V; Sungkanuparph S
    Int J Gen Med; 2024; 17():2163-2175. PubMed ID: 38770366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Impaired Kidney Function Among Adolescent Patients Hospitalized With Anorexia Nervosa.
    Gurevich E; Steiling S; Landau D
    JAMA Netw Open; 2021 Nov; 4(11):e2134908. PubMed ID: 34807260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study.
    Sise ME; Backman ES; Wenger JB; Wood BR; Sax PE; Chung RT; Thadhani R; Kim AY
    PLoS One; 2015; 10(4):e0124139. PubMed ID: 25923243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.